A Phase III Study Comparing Combined External Beam Radiation And Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone For Selected Patients With Intermediate Risk Prostatic Carcinoma
Principal Investigator
Bradley Prestidge, MD
Status
Terminated
Date Closed to Accrual
February 08 2012
Date of Study Termination
December 22 2022
Disease Site
Genitourinary [GU]
Prostate
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine whether combined external beam radiation (EBRT) and transperineal interstitial permanent brachytherapy will result in better freedom from progression (FFP) for 5 years compared to brachytherapy alone among selected patients with intermediate risk prostatic carcinoma.
Patient Population
Patients with locally confined adenocarcinoma of the prostate.
Target Accrual
586
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.